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Introduction: Cluster headache belongs to a group of primary headache entities: the trigeminal autonomic
cephalalgias. Cluster headache is the most common variant. The headache is usually severe and it is also associated
with autonomic symptoms. Secondary causes of cluster headache have been reported, such as intracranial artery
aneurysms and tumors. The question of when to carry out neuroimaging in patients with cluster headache is yet
unsettled. To the best of the author's knowledge, cluster headache associated with a clinically non-functioning
pituitary adenoma (chromophobe adenoma) has not been described. This case report describes the case of a man
with cluster headache where the evaluation showed a clinically non-functioning pituitary adenoma.
Case presentation: This case involved a 49-year-old Caucasian man who presented with a one-month history of
side-locked attacks of pain located in the right orbit. His symptoms fulfilled the criteria for cluster headache and a
diagnosis of cluster headache was made. The patient responded to symptomatic treatment. Enhanced magnetic
resonance imaging showed a pituitary adenoma. Further evaluations including hormonal screening revealed a
clinically non-functioning pituitary adenoma (chromophobe adenoma). After surgery to remove the tumor, his
headache attacks resolved totally.
Conclusion: Tumors have been reported in patients with cluster headache whose clinical attacks are identical to
genuine cluster headache. A clinically non-functioning pituitary adenoma can present as cluster headache. This
case emphasizes the need of imaging procedures in patients with cluster headache. Contrast-enhanced magnetic
resonance imaging including the sella turcica should always be done in patients with cluster headache.
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Cluster headache (CH) belongs to a group of primary
headache entities, the trigeminal autonomic cephalalgias.
CH is the most common variant. Studies have demon-
strated that CH has a lifetime prevalence of 0.12%. The
headache is usually severe and is associated with auto-
nomic symptoms. CH is more common in men and typ-
ically manifests itself between the third and fifth decades
of life. The question of when to carry out neuroimaging
in patients with CH is yet unsettled. Secondary causes of
CH have been reported in many cases, such as intracra-
nial artery aneurysms and tumors (symptomatic CH) [1].
The prevalence of symptomatic CHs is not identified be-
cause of a lack of prospective population-based studies.Correspondence: Bengt.Edvardsson@med.lu.se
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unless otherwise stated.CH associated with pituitary adenoma has been described
[2]. To the best of the author's knowledge. CH associated
with a clinically non-functioning pituitary adenoma (chro-
mophobe adenoma) has not been described. This case re-
port describes a man with typical CH in the setting of a
clinically non-functioning pituitary adenoma.
Case presentation
A 49-year-old Caucasian man presented with a one-
month history of side-locked attacks of excruciatingly se-
vere stabbing and boring right-sided pain located in his
orbit. The attacks were associated with nasal obstruction,
conjunctival injection, restlessness and migrainous fea-
tures such as nausea, photophobia and phonophobia. No
continuous background pain was identified. The duration
of the attacks was about 20 to 30 minutes with a
frequency of two to three per 24 hours. The attacks were
stereotypical, being exclusively right-sided with severeThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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headache. His medical and family history was otherwise
unremarkable. He was not on any medications and used
no drugs. His vital signs, a physical examination and a
neurological examination were normal. Laboratory test-
ing was normal. His symptoms fulfilled the revised
International Classification of Headache Disorders cri-
teria for CH.
A diagnosis of CH was made and subcutaneous suma-
triptan as well as high-flow oxygen were prescribed. A
prophylactic treatment with verapamil was prescribed.
He responded to the symptomatic treatment, with relief
within 15 minutes. A follow-up was planned. Because the
headache attacks continued, the patient was seen again
after two weeks. On arrival, a neurological examination
was normal. His visual fields were normal. He was taking
subcutaneous sumatriptan when required and verapamil
600mg daily. Owing to the relatively late onset of CH, en-
hanced magnetic resonance imaging (MRI) was ordered
to rule out an underlying lesion. It showed a rather large
pituitary tumor (20×21×17mm). No clear cavernous sinus
invasion could be demonstrated (Figure 1).
The patient had an operation to resect the tumor.
Histopathological examination including immunohisto-
chemistry verified the diagnosis of a non-functioning pi-
tuitary adenoma (chromophobe adenoma). Hormonal
screening showed no abnormalities: pituitary hormones
such as prolactin, insulin-like growth factor 1 and growth
hormone, thyroid-stimulating hormone and others were
within the normal ranges. His headache attacks resolvedFigure 1 Coronal T2-weighted magnetic resonance imaging of
the sella, showing a 20×21×17mm pituitary adenoma. No clear
cavernous sinus invasion can be demonstrated.totally after surgery. He remained headache-free and had
not experienced any headache attacks at follow-up after
17 months. The patient is regularly followed up in our
endocrine clinic.
Discussion
This case study involved a patient with CH respond-
ing to treatment. An assessment revealed a clinically
non-functioning pituitary adenoma. The patient be-
came headache-free after treatment and remained so
at follow-up.
Tumors have been documented in patients with CH.
The symptoms may be in line with the criteria for CH
[3,4]. Pituitary lesions have been reported within the
range of autonomic headache syndromes (trigeminal auto-
nomic cephalalgias). This had led to interest in the link be-
tween pituitary tumors and headache [5]. Headache is a
common symptom of pituitary disease. Levy et al. [5] ob-
served in a study of pituitary tumors and headache that 4%
of patients had CH. Functioning adenomas were above all
linked to CH. Prolactinomas may be particularly associated
with headache. Levy et al. [6] described a case of macro-
prolactinoma associated with CH, which responded to
dopamine agonists with complete resolution of the head-
ache. In a reappraisal, Mainardi et al. [2] found that pituit-
ary adenomas accounted for 3% of secondary CH cases.
The most frequent adenomas were prolactinomas.
The etiology and pathophysiology of CH are unknown.
The current hypothesis proposes that primary CH is
characterized by hypothalamic activation with secondary
activation of the trigeminal-autonomic reflex, probably
by a trigeminal-hypothalamic pathway [7]. In this case,
the tumor will be non-functioning. The underlying patho-
physiology could be due to the structural effects of the
tumor itself. Symptomatic CHs due to sellar pathology
have also been reported [1,8]. Olesen et al. [7] point to the
role of the cavernous sinus and/or hypophyseal region in
the pathophysiology of symptomatic CH. The trigeminal
nerve may be affected within the cavernous sinus and
hypophyseal region by the sympathetic, parasympathetic
and sensory fibers of the trigeminal nerve coming together
as a plexus in this region [7]. There are patients with pitu-
itary tumor-associated headache who have headache and
cranial autonomic symptoms on the same side as the le-
sion. A local mechanical effect or invasion may be import-
ant for the symptoms in those cases [9,10]. This structural
mechanism might have been involved in the pathophysi-
ology of this case.
However, there are studies that contradict this explan-
ation. These studies have failed to show an association
between cavernous sinus invasion or tumor volume and
headache [9,11]. Thus, a pituitary tumor-linked head-
ache may not just be a structural problem. It is likely
that CH due to sellar pathology has a more multifaceted
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remains to be illuminated.
Symptomatic CH should be suspected when the clin-
ical features of the headache are atypical and in patients
with pathological findings on neurological examination
[7]. Cittadini and Matharu [1] suggest that all patients
with CH should be evaluated for pituitary symptoms or
disease. They also advocate that enhanced MRI should
be carried out in all patients with CH who have an atyp-
ical symptomatology, abnormal examination, and a poor
response to the appropriate treatments. Many authors
propose that neuroimaging should be done in all patients
with CH [2,4,12]. The motive for this is that symptomatic
CH may be indistinguishable from typical episodic CH.
Conclusions
To the best of the author's knowledge, this is the first
report showing an association between CH and a clinic-
ally non-functioning pituitary adenoma (chromophobe
adenoma). All previous reports have shown an association
between CH and prolactinomas or a growth hormone-
producing adenoma. CH may be the presenting symptom
of a chromophobe adenoma of the pituitary. Symptoms
and objective signs of pituitary gland or pituitary region
disease are not always present, as in this case. Conse-
quently, the absence of pituitary symptoms or disease does
not exclude a symptomatic CH. Tumors have been re-
ported in patients with CH with clinical attacks identical
to genuine CH. This case emphasizes the need for imaging
procedures in patients with CH. Contrast-enhanced MRI
including the sella turcica should always be done in pa-
tients with CH.
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